|
Prevalence of pathogenic genetic variants in patients with gastric cancer ascertained through multi-gene panel testing. |
|
|
(OPTIONAL) Uncompensated Relationships - Invitae |
|
|
(OPTIONAL) Uncompensated Relationships - Invitae |
|
|
|
Stock and Other Ownership Interests - InVitae |
|
|
|
Stock and Other Ownership Interests - InVitae |
Travel, Accommodations, Expenses - InVitae |
|
|
Employment - Exact Sciences; InVitae |
Stock and Other Ownership Interests - Exact Sciences; InVitae |
|
|
|
Stock and Other Ownership Interests - Invitae |
Consulting or Advisory Role - Exir Bio; Taproot Health Inc |
Travel, Accommodations, Expenses - Velsera |
|
|
|
|
Stock and Other Ownership Interests - Caris Life Sciences; InVitae |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Guardant Health; JJ Innovative Medicine; Sebela Pharma |
Speakers' Bureau - Ambry Genetics |
Patents, Royalties, Other Intellectual Property - Abbvie; Medtronic; Myriad Genetics |
|
|
(OPTIONAL) Uncompensated Relationships - Invitae |